HQ: Bothell, Washington, United States

Seagen Contact Information – Key Personnel, Emails & Support Lines

seagen.com

About Seagen Company

Seagen is a clinical-stage biotechnology company dedicated to improving patient outcomes with advanced antibody-drug conjugate technology.

Seagen Specialization

Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics

Seagen General Information

HQ: Bothell, Washington, United States

Business Type: Public

Employees: 1001-5000

Rounds: Post-IPO Equity

Founded Date: 1998

Number of Exits: 2

Company Type: For Profit

Stock Symbol: NASDAQ:SGEN

Operating Status: Active

Last Funding Type: Post-IPO Equity

Phone Number: 6192707227

Last Investment Activity: Mar 12, 2024

Investments Activity: Mar 12, 2024 Mar 6, 2024 Mar 1, 2024

Seagen Email Format

{first_letter_first_name}{last_name}@seagen.com — 50.0% (example: ssmith@domain.com)

{first_name}@seagen.com — 33.3% (example: sarah@domain.com)

{first_name}.{last_name}@seagen.com — 8.3% (example: sarah.smith@domain.com)

{first_letter_first_name}.{first_letter_middle_name}.{last_name}@seagen.com — 8.3% (example: s.j.smith@domain.com)

Seagen General Seagen Emails

  • General Inquiries

    contact@seagen.com

  • Unclassified inbox

    pcarter@seagen.com

Contact details of 10 Seagen executives

Guy Padbury

Senior Vice President, Translational Sciences
  • Work email

    g******y@seagen.com

Bryce Mansfield

Executive Director, R&D Quality
  • Work email

    b********d@seagen.com

Kamran Ansari

VP, Head of Clinical Development Operations
  • Work email

    k*****i@seagen.com

Scott Orchard

Senior Vice President and Associate General Counsel, Head of Transactional Law
  • Work email

    s***********d@seagen.com

    Verified

Swapnil Bhargava

Director, BioProcess Development
  • Work email

    s*****l@seagen.com

    Verified

Wendel Doubleday

Sr. Director, Chemical Development
  • Work email

    w********y@seagen.com

    Verified

Mark Cooley

Executive Director, IT Strategy and Operations
  • Work email

    m**k@seagen.com

    Verified

Monique M. Greer

Vice President, Corporate Communications
  • Work email

    m*******r@seagen.com

    Verified

Michael Gerstle

Director
  • Work email

    m*****l@seagen.com

    Verified

Clay Siegall

Founder

Contact details of 5 Seagen other employees

Davina Sparks Henderson

Sr Manager. Field Reimbursement
  • Work email

    d********n@seagen.com

Virginie Oble Bouvet

Job not specified
  • Work email

    v***e@seagen.com

Peter Senter

VP, Chemistry,VP, Distinguished Research Fellow
  • Work email

    p***r@seagen.com

Marcel Koopman

International Product Manager Oncology
  • Work email

    m******n@seagen.com

Jayeshkumar Soneji

Job not specified
  • Work email

    j*****i@seagen.com

Similar Companies like Seagen

HQ: North Chicago, Illinois, United States

AbbVie

abbvie.com

AbbVie is a pharmaceutical company that discovers, develops,...

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 22, 2024

Founded Date: 2013

Number of Exits: 3

Company Type: For Profit

Stock Symbol: NYSE:ABBV

Operating Status: Active

HQ: Minneapolis, Minnesota, United States

Medtronic

medtronic.com

Medtronic develops healthcare technology solutions for vario...

HQ: Minneapolis, Minnesota, United States

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices Hospitals & Clinics

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Mar 27, 2024

Founded Date: 1949

Number of Exits: 28

Company Type: For Profit

Stock Symbol: NYSE:MDT

Operating Status: Active

HQ: New York, New York, United States

Pfizer is a biopharmaceutical company that provides affordab...

HQ: New York, New York, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,

Business Type: Public

Employees: 10001+

Rounds: Post-IPO Debt

Last Investment Activity: Sep 3, 2024

Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture

Founded Date: 1849

Number of Exits: 19

Company Type: For Profit

Stock Symbol: NYSE:PFE

Operating Status: Active

Investor Type: Corporate Venture Capital, Venture Capital


Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.